Dual-drug-loaded pH-responsive fiber scaffolds were successfully prepared by coaxial electrospinning. These were designed with the aim of being sutured into the resection site after tumor removal, to aid recovery and prevent cancer recurrence. The shell was made up of a mixture of gelatin and sodium bicarbonate (added to provide pHsensitivity), and was loaded with the anti-inflammatory drug ciprofloxacin; the core comprised poly(lactide-co-e-caprolactone) with the chemotherapeutic doxorubicin hydrochloride. Scanning electron microscopy revealed most fibers were smooth and homogeneous. Transmission electron microscopy demonstrated the presence of a clear core/shell structure. The fiber scaffolds were further characterized using infrared spectroscopy and X-ray diffraction, which proved that both drugs were present in the fibers in the amorphous form. The gelatin shells were cross-linked with glutaraldehyde to enhance their stability, and water contact angle measurements used to confirm they remained hydrophilic after this process, with angles between 10 and 35 . This is important for onward applications, since a hydrophilic surface is known to encourage cell proliferation. During in vitro drug release studies, a rapid and acid-responsive release of ciprofloxacin was seen, accompanied by sustained and long-term doxorubicin release. Both the release profiles and the mechanical strength of the fibers can effectively be tuned through the sodium bicarbonate content of the fibers: for instance, the break stress varies from 2.00 MPa to 2.57 MPa with an increase in sodium bicarbonate content. The pH values of aqueous media exposed to the scaffolds decrease only slightly, by less than 0.5 pH units, over the two-month timescale, suggesting that only minimal fiber degradation occurs during this time. The fiber scaffolds also have good biocompatibility, as revealed by in vitro cytotoxicity experiments. Overall, our results demonstrate that the novel scaffolds reported here are promising pH-sensitive drug delivery systems, and may be candidates for use after tumor resection surgery.
Introduction
In this work, we sought to develop pH-responsive dualdrug-loaded systems to be applied to tumor resection sites with the aim of preventing both infection and the recurrence of cancer. To do this, we employed the electrospinning technology, a simple route to prepare nanoscale fibers that has been widely explored in the context of biomaterials. 1 The simplest experiment, single-fluid spinning, applies electrical energy to a polymer solution containing a functional component (e.g. a drug), to yield monolithic fibers. A more sophisticated variant is coaxial electrospinning, where two different solutions are flowed through two concentrically arranged needles to produce core/shell architectures. The technique's simplicity, low cost, and the fact that a wide variety of materials can be processed, has led to many reports of electrospun fibers. 2, 3 Coaxial fibers have several benefits over the monolithic fibers from single fluid spinning, as a result of their more complex architectures allowing greater control over functional performance. For instance, a core/ shell structure can extend the period over which drug contained in the core is released if the shell comprises a blank polymer layer. In one such study, Yu et al. 4 used poly(e-caprolactone) (PCL) as the shell polymer and a mixture of a protein and polyethylene glycol as the core, and explored the relationship between drug release rate and shell thickness. It was found that a thicker shell layer slows down the rate of release. Drexler and Powell 5 prepared fibers with a PCL core and gelatin shell, and determined that the two polymers together led to materials with high biocompatibility (as a result of gelatin) and good mechanical properties (from PCL). In other work, Duan et al. 6 selected PCL as the core polymer and collagen as the shell, producing fibers which possess both good mechanical strength and high biocompatibility, and which they proposed might be used in vascular tissue engineering.
The tumor microenvironment is rather more acidic than the physiological pH and has a higher temperature, 7, 8 which offers the opportunity to target therapies. A number of pH-sensitive drug delivery systems have been reported. For example, Ulbrich et al. 9 synthesized hydrolyzed poly(maleic anhydride) and N-(2-hydroxypropyl) conjugates of acrylamide, and linked doxorubicin (DOX) to the polymer backbone. These conjugates were found to be stable at pH 7.4 but released their drug cargo at pH 5. Further, Chiang et al. 10 prepared a dual pH-and temperature-sensitive DOX-loaded nanogel based on pol(N-isopropylacrylamide); they were able to use temperature changes to regulate the loading of DOX, and control its release by changing the pH.
A number of electrospun systems with pH sensitivity have been reported. These typically used a pH-sensitive polymer (such as a Eudragit) as the basis for the fibers. Another route to achieve this is to use sodium bicarbonate (SB). For instance, Yuan et al. 11 fabricated acid-responsive electrospun fibers using an emulsion method (loading SB and ketoprofen into PLLA fibers), and in a previous study, we found that preparing gelatin fibers loaded with SB can lead to the pHresponsive release of ciprofloxacin. 12 In other work, Ke et al. 13 prepared a drug delivery system based on microspheres of poly(lactic-co-glycolic) acid containing DOX and SB, which exhibited the ability to target intracellular compartments with pHs lower than the general physiological pH. The incorporation of SB leads to acid sensitivity because it reacts with protons at low pH, generating CO 2 gas. This produces pores or ruptures in the drug-carrying vehicles, rapidly releasing the incorporated active ingredient. Thus, SB has been demonstrated in these pioneering studies to offer a simple and low-cost route to acid sensitivity. However, all these studies only looked at a single active ingredient.
The development of new cancer medicines is of great importance: data from the World Health Organization show that by 2020, the global incidence of cancer will increase by 50% over 2003 levels, which equates to an additional 15 million cancer patients per year.
14 The main treatments for cancer currently comprise surgery, radiotherapy, and chemotherapy. In general, surgical resection is the most effective treatment where tumors are accessible. 15 However, this can induce an infection, and inflammation associated with tumor-infiltrating inflammatory cells can affect the efficacy of adjuvant chemotherapies used alongside surgery. Chemotherapy also generally uses high doses of the active ingredients, which leads to numerous toxic side effects on the body. Regardless of the treatment used, recurrence of cancer is very common: relapse is seen in one of every five cancer cases. 16 One area of drug delivery in which electrospun fibers have attracted particular attention is that of anti-cancer medicines. In one example, Sedghi et al. 17 recently developed a curcumin-loaded monolithic system based on poly(vinyl alcohol) and chitosan, which they proposed have applications in post-operative chemotherapy. In another, DOX-loaded mesoporous, silica nanoparticles were incorporated into poly(L-lactic acid) (PLLA) fibers via electrospinning, giving systems from which DOX was released in a sustained manner. 18 In this paper, we sought to build on the literature reports to make multi-functional materials with both anti-inflammatory and anti-cancer properties. To do this, we fabricated acid-responsive fiber scaffolds carrying ciprofloxacin and DOX. The intention is that the fiber scaffolds can be sutured into the resection site after tumor removal. They were thus designed to provide an initial short-term release of ciprofloxacin, to inhibit any infection and post-operative inflammation, followed by long-term DOX release to destroy any residual cancerous tissue and avoid recurrence. The experimental rationale is illustrated in Figure 1 . A series of systems with different SB contents were prepared in the hope of tuning the drug release and mechanical properties. For the latter, we envisage that the scaffolds would be sutured into the resection site post-surgery to secure them in place. [19] [20] [21] This requires them to have a break stress in the range of 2 to 5 MPa. 22, 23 Ciprofloxacin is a quinolone drug which offers broad-spectrum antimicrobial activity with no serious side effects. 24 It was selected for inclusion in the fiber shell, with the goal of preventing post-operative infections. DOX hydrochloride, included in the core, is an anti-tumor drug which inhibits the synthesis of nucleic acids and has broad anti-tumor activity. The core polymer is poly(lactide-co-e-caprolactone) (PLCL), which can be fully hydrolyzed in vivo. The final degradation products of PLCL are water and carbon dioxide, and the intermediate products (lactic acids) are harmless to the human body in small quantities. 25 PLCL thus has good biocompatibility and does not lead to any toxic side effects in vivo. It has been widely used in tissue engineering of cartilage, bone, blood vessels, the liver, and the heart, inter alia. 26, 27 The presence of PLCL in the fibers made in this work can impart the fiber scaffolds with suitable mechanical properties for suturing, and since it hydrolyzes slowly 28 sustained release of the embedded DOX should occur and prevent recurrence. The shell polymer, gelatin, is a naturally occurring material with good biocompatibility and biodegradability, as well as a high degree of hydrophilicity. 29 It will thus ensure that the fiber scaffolds produced have a hygroscopic exterior, which is expected to enhance biocompatibility.
Experimental section

Materials
Gelatin (powder, purity > 99.5%) and glacial acetic acid were obtained from the Sinopharm Chemical Reagent Co., Ltd. DOX hydrochloride (DOX, purity > 99%) was procured from J&K Scientific Co. Ltd, while dimethyl sulfoxide (DMSO) and poly(lactide-co-e-caprolactone) (PLCL) (PCL:PLLA 
Electrospinning
A stainless steel co-axial spinneret (Changsha Nayi) was used for electrospinning. The spinneret dimensions were as follows: core needle inner diameter (ID) 0.346 mm and outer diameter (OD) 0.607 mm; shell needle ID 1.138 mm and OD 1.476 mm. A simple flat-tipped needle with an internal diameter of 0.5 mm was also employed to prepare monolithic control fibers. The core and shell solutions were prepared in HFIP, as detailed in Table 1 . All solutions were stirred for 24 h on a magnetic stirrer to ensure complete dissolution. For electrospinning, the appropriate solutions were loaded into 5 mL plastic syringes, and expelled through the co-axial spinneret with shell and core flow rates of 0.7 mL h À1 and 0.3 mL h
À1
, respectively. A high voltage power supply (ZGF-2000, Shanghai Sute Electrical Co. Ltd) was used to apply a voltage of 17 kV between the spinneret and an aluminium collector plate (10 Â 10 cm). Two syringe pumps (KDS100, ColeParmer) were used to drive the working fluids. The distance between the spinneret and collector plate was 23 cm. Control monolithic gelatin and Figure 1 . A schematic illustration of the experimental strategy used in this work.
PLCL fibers were similarly prepared, using a single needle and a flow rate of 0.5 mL h
. All experiments were performed at 25 C and 33-45% relative humidity. After about 7 h of electrospinning, the resultant fiber mats were dried in a vacuum chamber (DZF-6050, Shanghai Laboratory Instrument Work Co. Ltd) for 48 h at 25 C. The gelatin shells were then crosslinked. To do this, an aqueous solution of glutaraldehyde (25.0-28.0% (v/v); 10 mL) was placed in a petri dish at the bottom of a brown translucent desiccator, with the fibers above them. Crosslinking was allowed to proceed in the glutaraldehyde vapor for 9 h. All of the polymer solutions and fiber scaffolds containing DOX were stored away from light in order to prevent any degradation.
Fiber morphology
Fiber samples (1 Â 1 cm) were mounted on metal stubs using conductive double-sided tape, and then sputter coated with platinum under argon for about 40 s. A scanning electron microscope (SEM; JSM-5600 instrument, JEOL) was employed to investigate the morphological characteristics of the fibers. The ImageJ software (National Institutes of Health) was used to analyze the average diameter of each fiber sample. Around 50 fibers in the SEM images were randomly selected for this purpose.
Transmission electron microscopy (TEM; H-800 instrument, Hitachi) was additionally used to confirm the core/shell structure of the fibers. Samples for TEM were prepared by spinning directly onto copper TEM grids for a few seconds.
Fiber characterization
The water contact angles of the fiber surfaces were determined using a 322W instrument (Thermo Cahn). A water droplet (ca. 1 mL) was placed onto the surface of the fibers for this, with at least 10 measurements made (at 25 C) per fiber sample. Fourier-transform infrared spectroscopy (FTIR) was performed on a Nicolet-Nexus 670 FTIR spectrometer (Nicolet Instrument Corporation) over the scanning range of 600-4500 cm À1 and with a resolution of 2 cm
À1
. X-ray diffraction (XRD) patterns were collected over the 2h range 6-70 on a D/Max-BR diffractometer (Rigaku) supplied with Cu Ka radiation (40 kV/ 30 mA, k ¼ 1.5418 Å ). The mechanical properties of the cross-linked fibers were quantified on a HY-9940FS tensile testing machine (Shanghai Heng Yuyi Co., Ltd). Measurements were performed at 25 C and with a relative humidity of 70%; samples of the fiber scaffolds of 1 Â 5 cm (thickness 0.1-0.2 cm) were cut for these experiments. Five measurements were made for each fiber sample, and the results are reported as mean AE S.D.
In vitro ciprofloxacin and DOX release
The cross-linked drug-loaded fibers (100 mg) were immersed in centrifuge tubes containing 20 mL of PBS (pH ¼ 7.4) or acetate buffer (pH ¼ 5.0). The samples were incubated in a constant temperature incubator shaker at 37 C for three weeks with mild shaking (100 r/min). At predetermined time points, 1 mL of the test medium was withdrawn and an equal amount of fresh preheated PBS or AA buffer solution was added. The amount of drug released was quantified using an UV spectrophotometer (UV-1800, SHJH Company) at Table 1 . Details of the electrospinning solutions used in this study.
Sample
Shell solution
Core solution
Note: "G" denotes gelatin, "P" PLCL, and "S" sodium bicarbonate; "þ" indicates systems with a drug loading, and "-" those without drug. DOX: doxorubicin; PLCL: poly(lactide-co-e-caprolactone); SB: sodium bicarbonate.
277 nm (ciprofloxacin) or 480 nm (DOX), following construction of a calibration curve. Dilution was corrected for in the release calculations, and the cumulative release is expressed as a percentage of the theoretical drug loading in the fibers. Three measurements were made for each fiber sample, and the results are reported as mean AE S.D.
Antibacterial activity
The antibacterial activity of the fibers was measured using the zone of inhibition test method in LuriaBertani medium. E. coli (ATCC 29522) and S. aureus (ATCC 6538) were used as model Gram-negative and Gram-positive bacteria. The crosslinked fiber scaffolds were cut into circular discs (diameter ca. 14 mm), and then disinfected with three 2 h cycles of exposure to UV radiation prior to use. Bacteria were cultivated in the liquid medium for 12 h at 37 C in a rotary shaker. The pH of the medium was then adjusted to 6.8, and 100 mL (10 5 colony forming units) of the bacteria were loaded into a petri dish by the plate coating method. Next, the fiber samples were placed onto the plates. All the dishes were cultured at 37 C for 12 h before zones of inhibition were measured. Five measurements were made for each fiber sample, and the results are given as mean AE S.D.
In vitro cytotoxicity experiments
SMMC-7721 (a human liver cancer cell line) was employed to study the efficacy of the fibers in inducing the death of cancer cells, and L929 (mouse fibroblast) cells as a model non-cancerous cell line to explore the cytotoxicity of the scaffolds to normal cells. These cells were cultured in RPMI 1640 and DMEM medium, respectively. Before use, both RPMI 1640 and DMEM medium were supplemented with 1% (v/v) of a pre-made penicillin (100 units mL
À1
) and streptomycin (100 units mL
) solution, and 10% (v/v) fetal bovine serum. Cells were cultured in an incubator at 37 C and 5% CO 2 . Prior to experiments, trypsinization was used to separate the cells from the culture flask, after which they were recovered by centrifugation and diluted to a density of 2.0 Â 10 4 cells mL
. Fiber samples for in vitro studies were directly electrospun onto 14 mm cover slips, with 20 cover slips placed on the collector and electrospinning conducted for 7 h. The fibers were cross-linked with glutaraldehyde, and any residual glutaradehyde vapour was allowed to evaporate before cell culture experiments were performed.
The fiber-coated cover slips were placed in the wells of 24-well plates, with fiber-free slips as a negative control. The 24-well plates were sterilized under alcohol steam for 48 h and then washed twice with PBS to remove any residual ethanol. Next, 400 mL of RPMI 1640 (for SMMC-7721 cells) or DMEM (for L929 cells) was added to each well and the plate incubated for 0.5 h before 200 mL of dissociated SMMC-7721 or L929 cells at a density of 2.0 Â 10 4 cells mL À1 were seeded directly into each well. After one, three, or five days, the medium in each well was replaced by 40 mL of MTT solution (0.5% w/v) and 360 mL of fresh RPMI or DMEM. After incubation for 5 h, 400 mL DMSO was added to each well, and the plate placed on a shaker for 30 min at room temperature. Cell viability was then quantified in terms of absorption at 570 nm with the aid of a microplate reader (Multiskan, Thermo-Fisher). Each experiment contained triplicate conditions, and three independent experiments were performed.
Degradation studies
Approximately 0.1 g of each fiber sample was soaked in 20 mL of PBS or AA buffer solution in a 37 C incubator. After either three days or two months of incubation, the fiber samples were recovered and surface water removed. 1 Â 1 cm samples were then cut from the mats and analysed using SEM. The pH of the immersion medium was also quantified using a pH meter (PHS-3C, Inesa Instrument Co. Ltd). Five measurements were made for each fiber sample.
Statistical analysis
The experimental data are presented as mean AE SD. Statistical analysis was undertaken using one-way ANOVA. The threshold significance level was set at 0.05. Thus, p (probability) values lower than 0.05 were considered statistically significant.
Results and discussion
Fiber morphology
and GS 3 þ /P þ and reveals that the fiber scaffolds are largely smooth and homogeneous. The SEM images for GS 1
À /P À , and GS 3 À /P À can be found in the Supplementary Information, Figure S1 . Clearly, most of the fiber diameters are homogeneous, but some very fine fibers can also be observed. The diameter of the fibers increases with drug loading, which is presumably a result of the greater amount of solute per unit volume dispensed. The addition of SB causes the fiber diameters to become slightly larger (compare for instance Figure 2(a) and (b) ), but the amount of SB added has little effect on diameter. The diameters of monolithic drug-loaded gelatin and PLCL fibers have previously been reported to be smaller than these coaxial materials at 603 AE 126 nm and 732 AE 130 nm, respectively.
12
Figure 2(e) to (h) shows the drug-loaded fibers after cross-linking. The morphology has barely changed, but the fibers have become larger. There is also a decrease in the void volume of the fiber scaffolds after crosslinking, and they become slightly yellow in colour. Crosslinking with glutaraldehyde involves the reaction of free amino groups on the gelatin polypeptide chains with the aldehyde groups of glutaraldehyde (forming aldimine [CH ¼ N] linkages). 30 In the first step, the nucleophilic addition of e-NH 2 groups to carbonyl groups of the aldehyde results in the formation of carbinolamine, which is unstable. In the second step, protonation of the ÀOH group followed by loss of an H 2 O molecule leads to conjugated Schiff bases being generated. Therefore, new covalent bonds are formed between gelatin molecules both intramolecularly and intermolecularly. These result in the fiber scaffolds' mechanical strength and water resistance improving significantly, with an increased tensile strength having been reported after crosslinking. 31 The SB content (or lack thereof) has no effect on the post-cross-linking diameters.
TEM images (Figure 3 and S1) show the drugloaded fibers to have a clear core/shell structure. As the SB concentration increases, some solid particles (assumed to be SB) can be seen in the shell. This is expected to be because the concentration was above the SB solubility limit, and thus the shell working fluid comprised a suspension at higher concentrations. Nevertheless, at an SB concentration of 5% w/v, clear compartmentalized fibers can still be seen. However, when the SB content reaches 7%, a phase separation phenomenon arises. The GS 4 þ /P þ system shows a large number of solid particles on the surface of the fibers by 
and (e-h) the same fibers after cross-linking. The diameter distributions are shown below the images (AD: mean diameter; SD: standard deviation).
/P þ are drug-loaded coaxial fiber scaffolds with 0%, 1%, 3%, and 5% w/v SB in the shell solution respectively. Scale bar: 5 mm.
SEM, and no clear coaxial structure in TEM (see Figure S2 ). This formulation was thus excluded from further analysis.
Further characterization
FTIR spectra can be found in Figure 4 . Gelatin has peaks at 3296 cm À1 attributed to ÀOH or ÀNH stretching, and two broad peaks at about 1659 cm À1 and 1539
, which correspond to the stretching of the C ¼ O group (amide I), and the combined bending of N-H and stretching of C-N in the amide II band. 32 ) overlap with those of gelatin and PLCL. This can most likely be ascribed to the low drug loading and these peaks being masked by gelatin.
XRD patterns of the fibers ( Figure S3) show only broad haloes, demonstrating a lack of long-range order. The fibers hence comprise amorphous systems, with the drugs distributed in them at the molecular level. 34 
Contact-angle data and mechanical properties
Contact-angle data were collected to assess the wettability and hydrophilicity of the fiber membrane surfaces. This is important because it impacts the biocompatibility of the scaffolds, and the ability of cells to adhere to and proliferate on them. The results for all the samples are summarized in Table 2 . As expected, the fibers with gelatin shells all have hydrophilic surfaces with contact angles below 35 . PLCL is hydrophobic, and accordingly PLCL fibers have a high contact angle of >120
. The contact angle of the fibers decreases with an increase in the SB content in the shell, but only for SB concentrations up to 3% w/v (GS 2 þ /P þ ): a further increase in the concentration to 5% w/v in GS 3 þ /P þ makes little difference. Generally speaking, therefore, increasing the concentration of SB appears to increase the hydrophilicity of the fibers.
Comparing the drug-free and drug-loaded fibers, it can be seen that the addition of ciprofloxacin and Figure 3 . TEM images of the coaxial fibers: 
.1 * *p < 0.05 when compared with the analogous monolithic PLCL fibers. PLCL: poly(lactide-co-e-caprolactone).
DOX reduces the contact angle slightly, owing to their hydrophilic nature.
To probe the mechanical properties of the electrospun scaffolds, their tensile properties were recorded. Representative results are shown in Figure 5 .
All the fibers display similar behavior, as can be seen from the full data set in Table 3 . The two components of the fiber act synergistically to optimize the mechanical properties: PLCL has high strength, and as a result, the coaxial fibers show higher tensile strength values then gelatin alone. Conversely, gelatin has higher elongation at break, which is also imparted on the coaxial fibers such that they stretch more than pure PLCL before breaking. The results obtained are in line with those found in the literature. For instance Jaiswal et al. 35 prepared two types of polycaprolactone-gelatinhydroxyapatite scaffolds. One scaffold was prepared by depositing hydroxyapatite on electrospun polycaprolactone-gelatin fibers and the second by blend electrospinning. The break stress of the scaffolds was found to be ca. 3 MPa and ca. 1 MPa, respectively. The agglomeration of hydroxyapatite particles reduced the mechanical properties of the blend electrospun scaffold. In another study by Yaszemski et al., 36 a synthetic material to replace trabecular bone was developed and found to have a break stress of ca. 5 MPa. Zhou et al. 37 prepared a regenerated silk fibroin tubular scaffold using electrospinning and found it to have a tensile strength of 3.57 MPa, suitable for use in smalldiameter vascular grafts. Our fiber scaffolds are found to have break stresses within the range of 2-2.6 MPa and elongation at break of >20%. This suggests that they match the requirements for being sutured (a break stress of 2-5 MPa 23 ), and thus are suitable for use in resection sites. Figure 6 presents ciprofloxacin release profiles from the fiber scaffolds (compositions detailed in Table 1) in PBS (pH ¼ 7.4) or AA (pH ¼ 5.0). While the SB-free systems behave very similarly in both PBS and AA, acidic conditions are found to promote ciprofloxacin release in the SB-containing fibers. The latter bodes well for their use in treating infection, given that inflammation is known to lower the local pH. 38 The pH-sensitivity arises because at low pH, CO 2 gas is generated as SB reacts with protons, 39 creating channels and forming a porous structure through which the drug molecules can diffuse into the release medium (see Figure 1) . Typically, infections arise in the first few Coaxial fiber scaffold Gelatin Figure 5 . Stress/strain curves of monolithic gelatin and PLCL fibers, and the coaxial GS 3þ /P þ material. days after surgery, 40, 41 and thus the release rates observed from the fiber scaffolds match well with the clinical requirement.
Drug release
DOX release data can be found in Figure 7 . Release from a uniaxial PLCL fiber scaffold (Figure 7(a) ) shows rapid release over ca. 20 h in PBS (pH ¼ 7.4). In contrast, DOX release from the coaxial fibers in either PBS or AA buffer is much extended (Figure 7(b) ) as a result of the core/shell structure. 42 As with ciprofloxacin, pHsensitivity is observed for the SB-containing fibers, with more rapid release in AA. This is promising for the treatment of cancer, given the lower pH of the tumor microenvironment than general physiological conditions. Cancer can reoccur at a range of times after resection, from the first week to the second year. [43] [44] [45] The DOX release profiles are thus very promising to prevent recurrence in the early weeks after surgery.
The drug release rates are governed by the degradation and porosity of the fibers. After the scaffolds are immersed in a buffer solution, their void volume is reduced due to the swelling of the cross-linked gelatin (which can absorb water to form a hydrogel), 46 and this contributes to sustained release profiles. Over longer periods of time, the fibers will begin to degrade through hydrolysis, losing their mechanical and structural integrity and further promoting drug release. Clearly, the total amount of drug released is higher from the SBcontaining fibers, as is the rate of release (Table 4) . As discussed above, the SB can react in acidic media to form channels through which the drug can diffuse into Max release (%) the release medium. The greater the content of SB, the more channels which can form, and thus the faster the drugs are freed from the fibers and the greater the eventual cumulative percentage release obtained. SB on the scaffold surface can also enhance wettability, 47 which further promotes DOX and ciprofloxacin release. It is important to note that the results in Table 4 are fully consistent with clinical needs: the scaffolds given a rapid initial, pH-sensitive, release of ciprofloxacin to inhibit inflammation and infection, and long-term DOX release for the treatment of cancer.
In previous work, 12 we have explored ciprofloxacin release from monolithic PLCL/SB/drug and gelatin/ SB/drug fibers. We found that the former had no pHsensitivity, regardless of the SB loading, while the latter show pH-responsive release over around 24 h. By combining both PLCL and SB, we are able to obtain systems that are both pH sensitive and able to provide long-term sustained release. Figure 8 illustrates the antibacterial effects of the fiber scaffolds in terms of their inhibition zones. All the fibers have similar behavior, as can be seen from the full data set in Table 5 . The samples loaded with ciprofloxacin kill all the bacteria around them, resulting in a clear inhibition zone of 30-40 mm. Generally speaking, the inhibition zones against S. aureus are slightly greater than in the case of E. coli. This is consistent with the literature. 48 The addition of SB is found to have a small influence on the antibacterial properties of the fibers: the higher the SB content, the greater the inhibitory zone. This is consistent with the more rapid and greater extents of ciprofloxacin release observed with elevated SB concentrations.
Antibacterial activity
Biocompatibility
To evaluate the fibers' biocompatibility, cells were seeded onto the different scaffolds and their growth monitored over five days. The results of MTT cell viability measurements obtained with non-cancerous L929 cells are given for the drug-loaded fibers in Figure 9 (a) and for the drug-free analogues in Figure S4 (a). As expected, the number of cells present increases from day 1 to day 5 in all cases. Compared with the negative control (blank coverslips), there is a noticeable increase in the number of cells on all the fiber scaffolds, regardless of if they were drug-loaded or drug-free. Furthermore, an increase in the SB content (for instance from G þ /P þ to GS 3 þ /P þ ) led to an increase in cell growth due to the increase in surface wettability of the scaffolds. 49 Overall, the data demonstrate that Table 5 . Inhibition zone diameters for the coaxial fiber scaffolds.
Sample
Inhibition zone with E. coli (mm)
Inhibition zone with S. aureus (mm)
05 when compared with monolithic PLCL fibers, # p < 0.05 when compared with monolithic gelatin fibers. PLCL: poly(lactide-co-e-caprolactone). Figure 10 . SEM images of fiber scaffolds after degradation studies. Images and fiber diameter distributions (AD: mean diameter; SD standard deviation) are shown for (a) G þ /P þ (b) GS 1þ /P þ ; (c) GS 2þ /P þ ; and (d) GS 3þ /P þ after three days immersion in PBS, and (e-h) for the same fibers after three days in AA. Results obtained after two months' immersion are given in (i-l) for PBS and (m-p) for AA (pH 5.0). Scale bar: 5 mm.
the fibers are not toxic to non-cancerous cells, regardless of whether they have a drug loading or not.
The analogous data obtained with SMMC-7721 cells are presented in Figure 9 (b) and Figure S4 (b). A rapid increase in the number of SMMC-7721 cells on the drug-free scaffolds G Figure S4 (b), analogous to the findings with the non-cancerous L929 cells. In the case of the drug-loaded scaffolds, at all-time points studied there are fewer cells present than with the negative control. The drug-loaded scaffolds thus have the ability to inhibit the growth of cancer cells over the five-day time period. These data are promising for the intended application of the fibers, although it is not possible to draw any conclusions from them regarding the longer term performance of the fibers. However, given that DOX release continues over 26-30 days, it is thought that the fibers would continue to have efficacy over this period.
Scaffold degradation
SEM images of the fiber scaffolds after immersion in PBS or AA are presented in Figure 10 . The fibers have merged after immersion, and their diameters become thicker compared with the initial fibers. An increase in the amount of SB in the materials leads to the generation of solid particles on the surface of the fibers (see Figure 10 (h)). This is thought to be because CO 2 generated from the SB created channels in the fibers, permitting the migration of drug and SB to the fiber surface. These trends are apparent to a certain extent after three days, but are much clearer after two months' immersion. The reduction in void volume in the fibers is likely to explain the fact that drug release does not reach 100%: some of the drug is trapped deep inside the fibers, and as they swell and merge, it becomes increasingly difficult for these molecules to escape into the release milieu.
The pH values of the immersion buffers were also explored at the end of the experiment (Figure 11 ). In both buffers, there is a small (<0.5 pH units) decline in pH after two months. This is likely to be in part a result of HCl in the DOX salt being freed from the fibers. 50 The degradation products of gelatin and PLCL are also acidic materials, and these too will contribute to the lowering of the pH if freed into solution.
Overall, it is clear that partial degradation occurs over the two-month timescale. This compares favorably with the literature and clinical requirements. In a study by Cao and Kuboyama 51 porous scaffolds of polyglycolic acid and beta-tricalcium phosphate showed partial degradation 90 days after surgery. Wiltfang et al. 52 explored tricalcium phosphate implants into minipig tibial bone defects, and found 60% degradation after 16 weeks and 80% at 28 weeks. Hence, the fibers have suitable biodegradability to be employed to prevent cancer recurrence after the resection of tumors.
Conclusions
Novel pH-sensitive coaxial fibers carrying ciprofloxacin and DOX were prepared in this work, with the aim of making materials which could be implanted following tumor resection surgery. These were designed to provide an initial short-term release of ciprofloxacin to inhibit any infection and post-operative inflammation, followed by long-term DOX release to destroy any residual cancerous tissue and avoid recurrence. The fibers comprised a biocompatible gelatin shell loaded with ciprofloxacin and a poly(lactide-co-e-caprolactone) core containing DOX. SB was included in the shell to provide pH-sensitivity. The fibers were generally smooth and cylindrical in shape with clear core/ shell compartments. They have hydrophilic surfaces, as shown by contact angle measurements. In drug release experiments, the shell rapidly released ciprofloxacin over a few days to quickly eliminate any post-surgery infection or inflammation, while the core gave longterm release of DOX to kill any residual cancer cells and prevent recurrence. The results of cytotoxicity tests demonstrated that the drug-loaded fiber scaffolds stimulated the growth of non-cancerous cells owing to their hydrophilic surfaces, but were able to inhibit the proliferation of cancerous cells. The electrospun materials display appropriate mechanical properties for scaffold materials, and suitable biodegradability to act as bioresorbable systems. Overall, the materials prepared in this work have great potential to be used as implantable formulations in order to prevent the recurrence of tumor after resection surgery. Figure 11 . The pH values of buffer solutions after two months in contact with the fiber scaffolds.
